Back to Journals » ImmunoTargets and Therapy » Volume 12

ImmunoTargets and Therapy

ISSN: 2253-1556

Archive: Volume 12, 2023

Managing Cardiovascular Risk in Systemic Lupus Erythematosus: Considerations for the Clinician

Semalulu T, Tago A, Zhao K, Tselios K

ImmunoTargets and Therapy 2023, 12:175-186

Published Date: 8 December 2023

NOTCH1 Mutations Predict Superior Outcomes of Immune Checkpoint Blockade in Non-Small Cell Lung Cancer

Huang Q, Cao H, Yao Q, Zhou X, Li H, Bai Q, Hu H

ImmunoTargets and Therapy 2023, 12:165-173

Published Date: 5 December 2023

The Methylation in B7-H4 and BTLA Genes are Associated with the Risk of Pulmonary Tuberculosis

Cai XQ, Huang Q, Zhang TP

ImmunoTargets and Therapy 2023, 12:149-163

Published Date: 24 November 2023

Selinexor Synergistically Promotes the Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia by Inhibiting Glycolytic Function and Downregulating the Expression of DNA Replication Genes

Jiang J, Wang Y, Liu D, Wang X, Zhu Y, Tong J, Chen E, Xue L, Zhao N, Liang T, Zheng C

ImmunoTargets and Therapy 2023, 12:135-147

Published Date: 23 November 2023

Globoid Cell Leukodystrophy (Krabbe Disease): An Update

Maghazachi AA

ImmunoTargets and Therapy 2023, 12:105-111

Published Date: 31 October 2023

Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives

Ferrara CA, La Rocca G, Ielo G, Libra A, Sambataro G

ImmunoTargets and Therapy 2023, 12:79-89

Published Date: 26 July 2023

Novel Immunotherapies for Myasthenia Gravis

Nair SS, Jacob S

ImmunoTargets and Therapy 2023, 12:25-45

Published Date: 4 April 2023

Predictive Nomogram for Hyperprogressive Disease During Anti-PD-1/PD-L1 Treatment in Patients with Advanced Non-Small Cell Lung Cancer

Wang X, Guo Z, Wu X, Chen D, Wang F, Yang L, Luo M, Wu S, Yang C, Huang L, Fu L

ImmunoTargets and Therapy 2023, 12:1-16

Published Date: 4 January 2023